Description
What happens to bariatric surgery when GLP-1 medications like Ozempic, Wegovy, and Zepbound change the entire weight loss landscape?
In this episode, Dr. Matthew Weiner and registered dietitian Zoe unpack what they saw at the 2026 ASMBS annual conference - a meeting that felt very different from prior years. Surgical volumes are down, many bariatric surgeons are wrestling with what GLP-1s mean for their practices, and patients are left trying to figure out whether medication, nutrition, surgery, or some combination makes the most sense.
Dr. Weiner explains why bariatric surgery still matters, but no longer belongs in the same place in the treatment sequence. For many patients, a GLP-1 trial should come first. For others, especially non-responders, patients with severe diabetes, or people losing mobility, surgery may be the safest and most effective next step.
They also discuss why low-dose GLP-1s may be more sustainable than high-dose treatment, how to recognize a medication non-response, and why the best obesity care in 2026 combines nutrition, medication, surgery, and long-term support instead of forcing patients into one silo.
Timestamps:
00:20 - Fresh from the ASMBS Annual Conference
00:37 - What ASMBS Is and Why the Meeting Matters
02:05 - A Very Different Mood in Bariatric Surgery
04:49 - GLP-1s, Surgical Volume, and the Empty Zepbound Booth
06:24 - Why “Surgery vs. Medication” Misses the Point
08:36 - Private Practice, Pivoting, and Better Patient Care
09:12 - The Five Stages of Grief in Bariatric Surgery
11:38 - Why Patients Should Look for Comprehensive Obesity Care
12:54 - You Can Change Your Mind During Treatment
13:42 - How GLP-1 Response Changes Surgery Decisions
15:18 - High-Dose GLP-1s and Nutrition Challenges
17:02 - When Side Effects Make Stopping the Smart Choice
18:01 - Why Low-Dose GLP-1s Can Be More Sustainable
19:34 - Super Responders and Non-Responders
22:16 - How Long to Wait Before Considering Surgery
22:40 - Dose, Response, and When GLP-1s May Not Be Enough
24:34 - Severe Diabetes, Mobility Limits, and Surgical Timing
27:28 - Why 2026 Could Be the Year Obesity Became Treatable
28:26 - Breaking Out of Nutrition, Medication, and Surgery Silos
30:21 - The Pound of Cure App and New Free Tier
Download the Pound of Cure App: gololi.ai
AI-powered personalized weight loss planning, food logging, courses, support, and access to expert guidance.
https://apps.apple.com/us/app/loli-weight-loss/id6741747271
https://play.google.com/store/apps/details?id=com.digitalbariatrics.poundofcure
#GLP1 #BariatricSurgery #WeightLoss #Ozempic #Wegovy #Zepbound #ObesityMedicine #ASMBS #MetabolicSurgery #WeightLossSurgery #Nutrition #PoundOfCure